ID
46145
Description
Principal Investigator: Joel Gelernter, MD, Yale University School of Medicine, New Haven, CT, USA MeSH: Substance-Related Disorders,Cocaine-Related Disorders,Tobacco Use Disorder,Opioid-Related Disorders,Alcohol-Related Disorders https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000952 This study includes SSADDA (Semi Structured Assessment for Drug Dependence and Alcoholism) assessed subjects (mostly unrelated, but including some affected sibling pairs) recruited in the course of several substance dependence genetics projects. The sample includes 1,531 self-reported African-American (AA) subjects, 1,339 self-reported European-American (EA) subjects, and 2 who reported race as "unknown" or "missing".
Link
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000952
Keywords
Versions (2)
- 5/25/23 5/25/23 - Dr. med. Lucy Kessler
- 1/29/25 1/29/25 - Akane Nishihara
Copyright Holder
Joel Gelernter, MD, Yale University School of Medicine, New Haven, CT, USA
Uploaded on
January 29, 2025
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
dbGaP phs000952 Substance Dependence GWAS in European- and African - Americans
Eligibility Criteria
- StudyEvent: dbGaP phs000952 Substance Dependence GWAS in European- and African - Americans
- Eligibility Criteria
- Subject - Consent Information
- Pedigree Information
- Subject - Sample Mapping - Sample Use
- The dataset provides dependency data on cocaine, marijuana, opioids, sedatives, stimulants, tobacco (affected/not affected) and alcohol (n=8 variables, including symptoms of tolerance and withdrawl), in addition to querying for absence/presence of other mental diseases, e.g. ADHD, agoraphobia, bipolar disorders, obsessive-compusive disorder, schizophrenia.
- Sample - Attribute Information
Similar models
Eligibility Criteria
- StudyEvent: dbGaP phs000952 Substance Dependence GWAS in European- and African - Americans
- Eligibility Criteria
- Subject - Consent Information
- Pedigree Information
- Subject - Sample Mapping - Sample Use
- The dataset provides dependency data on cocaine, marijuana, opioids, sedatives, stimulants, tobacco (affected/not affected) and alcohol (n=8 variables, including symptoms of tolerance and withdrawl), in addition to querying for absence/presence of other mental diseases, e.g. ADHD, agoraphobia, bipolar disorders, obsessive-compusive disorder, schizophrenia.
- Sample - Attribute Information
C0680251 (UMLS CUI [1,2])
C0524662 (UMLS CUI [1,2])
C0600427 (UMLS CUI [1,3])
C0038586 (UMLS CUI [1,4])
C0680251 (UMLS CUI [2,1])
C0036341 (UMLS CUI [2,2])
C0005586 (UMLS CUI [2,3])
C4534351 (UMLS CUI [2,4])
C3554639 (UMLS CUI [2,5])